Sources: Adar Poonawalla’s SII gets legal notice from AstraZeneca

Sources: Adar Poonawalla’s SII gets legal notice from AstraZeneca
Image Credits: Adar Poonawalla/Twitter

AstraZeneca has served legal notice to Indian COVID-19 vaccine maker, Serum Institute of India (SII) over the delay in the vaccine delivery, according to reports.

This comes a day after the SII CEO Adar Poonawalla admitted that his company’s capacity to produce Covishield was very stressed.

Click here to read more India stories

“The globe needs this vaccine and we are prioritising the needs of India at the moment and we are still short of being able to supply… to every Indian that needs it,” Poonawalla said.

The export of vaccines was not completely banned, the central government had said last week.

SII produces 60 to 65 million doses every month. It has so far supplied 100 million doses to the central government and 60 million to other countries, the company CEO Adar Poonawalla said.

He also talked about the need for Rs 3,000 crore to improve the company’s production capacity by June.

“We’re supplying in India at approximately ₹ 150-160. The average price is around $20 (Rs 1,500)… (but) because of the Modi government’s request, we are providing at subsidised rates… It is not that we’re not making profits… but we are not making super profits, which is key to re-investing,” he said.

“This (the amount needed) would be roughly ₹ 3,000 crores. The process takes 85 days, so it would be just under three months before we scale up operations,” he said.

ALSO READ: Delhi HC: Mask Is Compulsory Even If You Are Alone In Car